Liposomal bupivacaine during robotic throat surgery
Treatments studied
Part of Cancer, Digestive system, Ear, nose & throat, Mouth & dental, Pain clinical trials.
This study gives a pain-relief medicine (bupivacaine in a slow-release form) during transoral robotic throat surgery. It aims to see if it improves comfort and pain control around the time of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are having transoral robotic surgery (a throat/mouth robotic procedure)
- You can understand the study and sign consent
- You do not have an allergy to bupivacaine or similar numbing medicines called “amide anesthetics”
- You do not have carnitine deficiency
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a small piece of your own cheek fat to fill the surgical site after robotic throat surgery can lower pain and opioid use. It is for people with early-stage tonsil cancer or salivary gland tumors.
This study compares different pain-relief medications given during lung surgery to see which one controls pain better. It may help people have less post-surgery pain after robotic wedge resection or lobectomy.
This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.
This trial tests a long-acting painkiller injected during surgery to see if it reduces pain after keyhole (laparoscopic) procedures like gallbladder removal, hernia repair, or appendix removal. It may help you need fewer opioids and recover more comfortably.
This study tests a long-acting numbing medicine (liposomal bupivacaine) to see if it helps control pain after brain tumor surgery. If you are having a specific type of craniotomy and do not have certain health conditions, you may be able to join.
This trial tests whether a long-acting numbing medication (liposomal bupivacaine) injected into the abdominal wall can reduce pain after laparoscopic surgery for gynecologic cancer. If effective, it may help patients recover with less discomfort and fewer painkillers.
Hear when a new Oropharyngeal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.